Clinical Trials on Psychotic Disorder in United States

Total 60490 results

University of Ulster

Completed

Walking for Health: an Intervention to Increase Physical Activity and Reduce Sedentary Behaviour in People With SMI (WORtH)

Schizophrenia | Bipolar Disorder | Major Depression | Mental Illness | Psychosis

Ireland, United Kingdom
VA Office of Research and Development
VA Maryland Health Care System

Recruiting

Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness (CPSMI)

Psychotic Disorders | Schizophrenia | Chronic Pain | Bipolar Disorder | Affective Disorders, Psychotic

United States
University of Maryland, Baltimore
National Center for Complementary and Integrative Health (NCCIH)

Recruiting

Prebiotic Treatment in People With Schizophrenia (FOCIS)

Schizophrenia | Schizoaffective Disorder

United States
Columbia University
National Institute of Mental Health (NIMH)

Completed

Motivation Skills Training for Schizophrenia (MST)

Schizophrenia | Schizoaffective Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder

Schizophrenia

United States
Sheppard Pratt Health System

Completed

Sulforaphane to Reduce Symptoms of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
National Institute of Mental Health (NIMH)

Completed

Effects of Modafinil on Brain Function in Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
University of Maryland, Baltimore

Completed

Schizophrenia and the Gut Microbiome

Schizophrenia | Schizoaffective Disorder

United States
Emory University

Completed

Minocycline Augmentation to Clozapine

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH); National Alliance for Research...

Terminated

Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)

Schizophrenia | Schizoaffective Disorder

United States
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Treatment of Schizophrenia Through Internet-Based Psychoeducation

Schizophrenia | Schizoaffective Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Broad Effectiveness: Study With Aripiprazole

Schizophrenia | Schizoaffective Disorder

United States
University of Massachusetts, Worcester

Completed

Effect of Single Dose Intranasal Insulin On Cognitive Function

Schizophrenia | Schizoaffective Disorder

United States
University of Pennsylvania
National Alliance for Research on Schizophrenia and Depression

Completed

Cognitive Therapy for Negative Symptoms and Functioning

Schizophrenia | Schizoaffective Disorder

United States
Louisiana State University Health Sciences Center...
SAM Technology & The San Francisco Brain Research Institute

Terminated

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)

Schizophrenia | Schizoaffective Disorder

United States
Vanderbilt University
National Alliance for Research on Schizophrenia and Depression; Cephalon

Completed

Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
North Suffolk Mental Health Association

Completed

A Comparison of Two Cognitive Batteries in People With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
North Suffolk Mental Health Association
Janssen Medical Affairs

Completed

Galantamine for Cognition in People With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
North Suffolk Mental Health Association
Massachusetts General Hospital

Completed

The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
University of Massachusetts, Worcester
Intra-Cellular Therapies, Inc.

Recruiting

Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia

Schizophrenia | Schizo Affective Disorder

United States
University of Maryland, Baltimore

Recruiting

Ketogenic Diet in People With Schizophrenia

Schizophrenia | Schizo Affective Disorder

United States
Vishwajit Nimgaonkar, MD PhD
Stanley Medical Research Institute

Recruiting

Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia (CATOS)

Schizophrenia | Schizo Affective Disorder

United States
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA); Columbia University; University of Vermont and other collaborators

Completed

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

Schizophrenia | Schizoaffective Disorder | Dual Diagnosis | Psychotic Disorder | Cannabis Use Disorder

United States
Deepak Sarpal
National Institute of Mental Health (NIMH)

Recruiting

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

Schizophrenia | Schizoaffective Disorder

United States
National Institute of Mental Health (NIMH)

Recruiting

Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography

Schizophrenia | Schizoaffective Disorder

United States
University of Texas Southwestern Medical Center
National Institute of Mental Health (NIMH)

Active, not recruiting

Database Registry for Neural Network Biomarkers in Psychosis (Imaging)

Schizophrenia | Schizoaffective Disorder

United States
University of Maryland, Baltimore

Completed

Prebiotic Treatment in People With Schizophrenia - Pilot Study (preFOCIS)

Schizophrenia | Schizoaffective Disorder

United States
The University of Texas at Dallas

Completed

Stimulating the Brain to Improve Self-Awareness

Schizophrenia | Schizoaffective Disorder

United States
University of Massachusetts, Worcester
Stanley Medical Research Institute

Completed

Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
Nathan Kline Institute for Psychiatric Research

Completed

Remediation of Auditory Recognition in Schizophrenia With tDCS

Schizophrenia | Schizoaffective Disorder

United States
University of Maryland, Baltimore
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Alliance...

Completed

Biomarker Study of Acamprosate in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
University of Maryland, Baltimore
National Institute of Mental Health (NIMH)

Completed

Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
University of Colorado, Denver
National Institute of Mental Health (NIMH)

Completed

Nicotinic Receptors and Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Sheppard Pratt Health System
Stanley Medical Research Institute

Completed

Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Icahn School of Medicine at Mount Sinai
Brain & Behavior Research Foundation

Completed

Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
Stanley Medical Research Institute

Completed

Kuvan in People With Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Northwestern University
Brain & Behavior Research Foundation; Neurocentria, Inc.

Completed

Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Northwestern University
National Alliance for Research on Schizophrenia and Depression

Completed

Serotonin 1A Agonists and Cognition in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
VA Office of Research and Development
Minneapolis Veterans Affairs Medical Center; Veterans Medical Research Foundation

Completed

Remediation of Working Memory in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute

Completed

Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders

Schizophrenia | Schizoaffective Disorder

United States
Emory University
Janssen, L.P. - Investigator Initiated Studies Program

Completed

Risperdal Consta and Health Care Utilization in Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Louisiana State University Health Sciences Center...
Bristol-Myers Squibb

Terminated

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)

Schizophrenia | Schizoaffective Disorder

United States
The University of Texas at Dallas

Active, not recruiting

The Efficacy of Neural Stimulation in Individuals With Schizophrenia

Schizophrenia | Schizo Affective Disorder

United States
Johns Hopkins University

Completed

Cognitive Effects of Nimodipine in Patients With Schizophrenia

Schizophrenia | Schizo Affective Disorder

United States
VA Office of Research and Development
Stanford University; University of South Carolina

Completed

Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic Stimulation

Schizophrenia | Schizoaffective Disorder

United States
Janssen Scientific Affairs, LLC

Completed

Sustainable Early Episode Clinic Study (SEEC) (SEEC)

Schizophrenia | Schizoaffective Disorder

United States
Duke University

Completed

Theta Burst Stimulation for Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Yale University

Terminated

A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia (CRC)

Schizophrenia | Schizoaffective Disorder

United States
Nathan Kline Institute for Psychiatric Research
Columbia University

Unknown

N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
US Department of Veterans Affairs

Completed

Cognitive - Behavioral Therapy

Schizophrenia | Schizoaffective Disorder

United States

Clinical Trials on Psychotic Disorder in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations